Anuh Pharma Limited

BSE:506260 Stock Report

Market Cap: ₹11.5b

Anuh Pharma Past Earnings Performance

Past criteria checks 4/6

Anuh Pharma has been growing earnings at an average annual rate of 24.5%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 15% per year. Anuh Pharma's return on equity is 19.5%, and it has net margins of 9.2%.

Key information

24.5%

Earnings growth rate

24.5%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate15.0%
Return on equity19.5%
Net Margin9.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Anuh Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:506260 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,3995902190
30 Jun 246,2345782110
31 Mar 246,4706012070
31 Dec 236,4045431970
30 Sep 236,0714451900
30 Jun 235,7264061850
31 Mar 235,2753621800
31 Dec 224,9913551740
30 Sep 224,9213361680
30 Jun 224,8583231620
31 Mar 224,8663061570
31 Dec 214,5482251520
30 Sep 214,2151931520
30 Jun 214,2501731540
31 Mar 214,3202841510
31 Dec 204,0692661520
30 Sep 203,8442881490
30 Jun 203,4632521370
31 Mar 203,0701431390
31 Dec 193,1802051360
30 Sep 193,1211961260
30 Jun 193,2532351220
31 Mar 193,2072341140
31 Dec 183,0472131210
30 Sep 182,9932081190
30 Jun 182,6651601140
31 Mar 182,3811651090
31 Dec 172,315161940
30 Sep 172,155194870
30 Jun 172,087193800
31 Mar 172,061201790
31 Dec 162,209181670
30 Sep 162,476191690
30 Jun 162,887217700
31 Mar 163,262258700
31 Dec 153,2612571390
30 Sep 153,1552611360
30 Jun 152,9522351320
31 Mar 152,837220590
31 Dec 142,8942271320
30 Sep 142,8992131280
30 Jun 142,8622071260
31 Mar 142,6641761230

Quality Earnings: 506260 has a high level of non-cash earnings.

Growing Profit Margin: 506260's current net profit margins (9.2%) are higher than last year (7.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 506260's earnings have grown significantly by 24.5% per year over the past 5 years.

Accelerating Growth: 506260's earnings growth over the past year (32.6%) exceeds its 5-year average (24.5% per year).

Earnings vs Industry: 506260 earnings growth over the past year (32.6%) exceeded the Pharmaceuticals industry 20.5%.

Return on Equity

High ROE: 506260's Return on Equity (19.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 01:24
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anuh Pharma Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research